CANbridge Pharmaceuticals Inc. (HKG:1228)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Medical Products	92.27M
Medical Products Growth	-18.83%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Other Regions	47.85M
Other Regions Growth	-7.86%
China	44.42M
China Growth	-28.05%